{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:26:39Z","timestamp":1793154399618,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejogrb.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:03:57Z","timestamp":1536681837000},"page":"6-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Vaginal progesterone for the prevention of preterm birth and the risk of gestational diabetes"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-896X","authenticated-orcid":false,"given":"Yaniv","family":"Zipori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Matanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Beloosesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (9832)","key":"10.1016\/j.ejogrb.2018.09.011_bib0005","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.ejogrb.2018.09.011_bib0010","first-page":"B11","article-title":"The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth","volume":"216","author":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"September (3)","key":"10.1016\/j.ejogrb.2018.09.011_bib0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth \u2264 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"November (24)","key":"10.1016\/j.ejogrb.2018.09.011_bib0020","doi-asserted-by":"crossref","first-page":"15644","DOI":"10.1073\/pnas.202612199","article-title":"Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation","volume":"99","author":"Picard","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2018.09.011_bib0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.diabres.2013.11.003","article-title":"Global estimates of the prevalence of hyperglycaemia in pregnancy","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract."},{"issue":"June (6)","key":"10.1016\/j.ejogrb.2018.09.011_bib0030","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dc13-2717","article-title":"Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010","volume":"37","author":"Feig","year":"2014","journal-title":"Diabetes Care"},{"issue":"May (19)","key":"10.1016\/j.ejogrb.2018.09.011_bib0035","first-page":"1991","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"September (9)","key":"10.1016\/j.ejogrb.2018.09.011_bib0040","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/dc07-0564","article-title":"Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery","volume":"30","author":"Rebarber","year":"2007","journal-title":"Diabetes Care"},{"issue":"July (1)","key":"10.1016\/j.ejogrb.2018.09.011_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/AOG.0b013e3181a9454b","article-title":"Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy","volume":"114","author":"Waters","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"October (4)","key":"10.1016\/j.ejogrb.2018.09.011_bib0050","article-title":"Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies","volume":"201","author":"Gyamfi","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"December (10)","key":"10.1016\/j.ejogrb.2018.09.011_bib0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1055\/s-0031-1280854","article-title":"The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17\u03b1-hydroxyprogesterone caproate","volume":"28","author":"Wolfe","year":"2011","journal-title":"Am J Perinatol"},{"issue":"6","key":"10.1016\/j.ejogrb.2018.09.011_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2013.04.027","article-title":"Progesterone is not the same as 17\u03b1-hydroxyprogesterone caproate: implications for obstetrical practice","volume":"208","author":"Romero","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"December (7)","key":"10.1016\/j.ejogrb.2018.09.011_bib0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-9378(82)90349-0","article-title":"Criteria for screening tests for gestational diabetes","volume":"144","author":"Carpenter","year":"1982","journal-title":"Am J Obstet Gynecol"},{"issue":"November (20)","key":"10.1016\/j.ejogrb.2018.09.011_bib0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"issue":"September (3)","key":"10.1016\/j.ejogrb.2018.09.011_bib0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0010-7824(91)90014-7","article-title":"Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone","volume":"44","author":"Ball","year":"1991","journal-title":"Contraception"},{"issue":"August (6)","key":"10.1016\/j.ejogrb.2018.09.011_bib0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.280.6.533","article-title":"Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus","volume":"280","author":"Kjos","year":"1998","journal-title":"JAMA"},{"issue":"July (7)","key":"10.1016\/j.ejogrb.2018.09.011_bib0085","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Women\u2019s health initiative investigators. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the women\u2019s health initiative hormone trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"issue":"May (10033)","key":"10.1016\/j.ejogrb.2018.09.011_bib0090","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"OPPTIMUM study group. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2018.09.011_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","article-title":"Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data","volume":"218","author":"Romero","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"May","key":"10.1016\/j.ejogrb.2018.09.011_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejogrb.2014.02.009","article-title":"Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques","volume":"176","author":"Ashrafi","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"July (Suppl 2)","key":"10.1016\/j.ejogrb.2018.09.011_bib0105","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.2337\/dc07-s206","article-title":"Increasing prevalence of gestational diabetes mellitus: a public health perspective","volume":"30","author":"Ferrara","year":"2007","journal-title":"Diabetes Care"},{"issue":"March (6)","key":"10.1016\/j.ejogrb.2018.09.011_bib0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7326\/M13-2905","article-title":"U.S. Preventive services task force. Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518309692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518309692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:42:13Z","timestamp":1759556533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211518309692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":22,"alternative-id":["S0301211518309692"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.09.011","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal progesterone for the prevention of preterm birth and the risk of gestational diabetes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}